Rola skladnikow odzywczych w lagodzeniu objawow choroby Alzheimera

• Autorzy: Przyslawski J , Stelmach M

Warianty tytułu

EN

The role of nutrients in the relieve of Alzheimer disease's symptoms

• Języki publikacji: PL

Abstrakty

PL

Jedną z chorób neurodegeneracyjnych o nierozpoznanej do końca etiologii jest choroba Alzheimera. Wśród wielu czynników związanych z jej rozwojem wymienia się między innymi stres oksydacyjny, choroby sercowo-naczyniowe, występowanie allelu ɛ-4 apolipoproteiny E (35). Coraz większą uwagę zwraca się także na rolę żywienia, a konkretnie wybranych składników odżywczych występujących w żywności, które mogą mieć wpływ na jej przebieg, a być może także zmniejszenie ryzyka jej rozwoju (4, 51). Przedstawiona praca jest próbą usystematyzowania aktualnej wiedzy na temat wzajemnych powiązań pomiędzy sposobem żywienia i jego ewentualnym wpływem na wystąpienie tej choroby.

EN

Alzheimer disease is one of the neurodegenerative diseases of unknown etiology. Among risk factors connecting with its development on Alzheimer disease are listed: oxidative stress, cardiovascular diseases, and the presence of the apolipoprotein E - ɛ-4 allele. Nutrition, especially selected nutritional components are consider to play the most important role in its etiology, because of the influence on the course of the disease and even maybe on decreasing the risk of its development or prevention. The presented essay is a kind of systematic review considering the connection of nutritional habits and possible influence on the presence of Alzheimer disease.

Słowa kluczowe

PL

choroby czlowieka; objawy chorobowe; choroba Alzheimera; ludzie chorzy; skladniki odzywcze; zywienie czlowieka; lagodzenie objawow chorobowych

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2008
• Tom: 35
• Numer: 4
• Opis fizyczny: s.332-339,rys.,tab.,bibliogr.

Twórcy

autor

Przyslawski J

• Katedra i Zaklad Bromatologii, Uniwersytet Medyczny im.K.Marcinkowskiego w Poznaniu, ul.Marcelinska 42, 60-354 Poznan

autor

Stelmach M

• Katedra i Zaklad Bromatologii, Uniwersytet Medyczny im.K.Marcinkowskiego w Poznaniu, ul.Marcelinska 42, 60-354 Poznan

Bibliografia

• 1. Ascherio A.: Antioxidants and stroke. Am. J. Clin. Nutr., 2000,72,327.
• 2. Barberger-Gateau P., Raffaitin C., Letenneur L., et al.: Dietary patterns and risk of dementia. Neurology 2007,69,1921.
• 3. Bays H.E.: Safety Considerations with Omega-3 Fatty Acid Therapy. Am. J. Cardiol., 2007, 99,6A, 35.
• 4. Bell I.R.: Diet and nutrition in Alzheimer’s disease and other dementias of late life. Explore 2005, 1, 4, 299.
• 5. Belleville J.: The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. Nutrition 2002,18, 173.
• 6. Berr C., Richard M.J., Roussel A.M., et al.: Systemic oxidative stress and cognitive performance in the population-based EVA study. Free Radic. Biol. Med., 1998, 24, 1202.
• 7. Bertelli A.A., Migliori M., Panichi V., et al.: Oxidative stress and inflammatory reaction modulation by white wine. Ann. NY. Acad. Sci., 2002,957,295.
• 8. Bray G. A., Lovejoy J.C., Smith S.R., et al.: The influence of different fats and fatty acids on obesity, insulin resistance and inflammation. J. Nutr., 2002, 132, 2488.
• 9. Brookmeyer R., Johnson E., Ziegler-Graham K., et al.: Forecasting the global burden of Alzheimer’s disease. Alzheimer’s and Dementia 2007, 3,186.
• 10. Butterfield D.A., Castegna A., Drake J., et al.: Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutr. Neurosci., 2002,5,229.
• 11. Cohn J.S.: Oxidized fat in the diet, postprandial lipaemia and cardiovascular disease. Curr. Opin. Lipidol., 2002,13,19.
• 12. Cowan D.T., Roberts J.D., Fitzpatrick J.M., et al.: Nutritional status of older people in long - term care settings: current status and future directions. Int. J. Nurs. Stud., 2004, 41, 225.
• 13. Crystal H.A., Ortof E., Frishman W.H., et al.: Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J. Am. Geriatr. Soc., 1994, 42, 933.
• 14. Curtain C.C., Ali F., Volitakis I., et al.: Alzheimer’s disease amyloid - beta binds copper and zinc to generate an allosterically ordered membrane - penetrating structure containing superoxide dismutase - like subunits. J. Biol. Chem., 2001, 276, 20466.
• 15. Engelhart M.J., Geerlings M.I., Ruitenberg A., et al.: Diet and risk of dementia: does fat matter? Neurology 2002, 59, 1915.
• 16. Fisher A., Naughton D.P.: Why nutraceuticals do not prevent or treat Alzheimer‘s disease. Nutrition 2005, 4, 14.
• 17. Förstl H., Maelicke A., Weichel C.: Demenz Taschenatlas special. Stuttgart, Thiemie Verlag, 2005.
• 18. Hardy J.A., Higgins G.A.: Alzheimer’s disease: the amyloid cascade hypothesis. Science 1992, 256,184.
• 19. He K., Merchant A., Rimm E.B., et al.: Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 2004, 35,169.
• 20. Heinonen I.M., Lehtonen P.J., Hopia A.I.: Antioxidant activity of berry and fruit wines and liquors. J. Agric. Food. Chem., 1998,46,25.
• 21. Honig L.S., Tang M.X., Albert S., et al.: Stroke and the risk of Alzheimer disease. Arch. Neurol., 2003, 60, 1707.
• 22. Hooijmans C.R., Rutters F., Dederen P.J., et al.: Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD). Neurobiol. Dis., 2007,28,16.
• 23. Howard A., Chopra M., Thurnham D., et al.: Red wine consumption and inhibition of LDL oxidation: what are the important components? Med. Hypotheses 2002,59, 101.
• 24. Hu F.B., Willett W.C.: Optimal diets for prevention of coronary heart disease. J. Am. Med. Assoc., 2002, 288, 2569.
• 25. Huang X., Cuajungco M.P., Atwood C.S., et al.: Cu (II) potentiation of Alzheimer Abeta toxicity. Correlation with cell - free hydrogen peroxide production and metal reduction. J. Biol. Chem., 1999, 274, 37111.
• 26. Kalmijn S., Launer L.J., Lindemans J., et al.: Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study. Am. J. Epidemiol., 1999, 150, 283.
• 27. Kessler H., Pajonk F.G., Supprian T., et al.: Zur Bedeutung von Kupfer für die Pathophysiologie der Alzheimer-Krankheit. Nervenarzt 2005,76, 581.
• 28. Launer L.J.: Is there epidemiologic evidence that antioxidants protect against disorders in cognitive function? J. Nutr. Health Aging 2000, 4,197.
• 29. Laurin D., Foley D.J., Masaki K.H., et al.: Vitamin E and C supplements and risk of dementi. J. Am. Med. Assoc., 2002,288,2266.
• 30. Leboeuf R.: Homocysteine and Alzheimer’s disease. J. Am. Diet. Assoc., 2003,103,304.
• 31. Lim G.P., Calon F., Morihara T., et al.: A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model. J. Neurosci., 2005, 25,12, 3032.
• 32. Luchsinger J.A., Min-Xing T., Shea S., et al.: Caloric intake and the risk of Alzheimer disease. Arch. Neurol., 2002, 59, 1258.
• 33. Luchsinger J.A., Tang M.X., Shea S., et al.: Plasma homocysteine levels and risk of Alzheimer’s disease. Neurology 2004, 62, 1972.
• 34. Luchsinger J.A., Noble J.M., Scarmeas N.: Diet and Alzheimer’s Disease. Curr. Neurol. Neurosci. Rep., 2007, 7, 366.
• 35. Luchsinger J.A., Mayeux R.: Dietary factors and Alzheimer’s disease. Lancet Neurol., 2004, 3, 579.
• 36. Luchsinger J.A., Tang M.X, Shea S., et al.: Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004, 63, 1187.
• 37. Morris M.C.: Diet and Alzheimer’s Disease: What the Evidence Shows. Med. Gen. Med., 2004,6,1, 48.
• 38. Morris M.C., Beckett L.A., Scher P.A., et al.: Vitamin E and C supplements use and risk of incident Alzheimer disease. Alzheimer Dis. Assoc. Disorder 1998, 12,121.
• 39. Mukamal K.J., Kuller L.H., Fitzpatrick A.L., et al.: Prospective study of alcohol consumption and risk of dementia in older adults. J. Am. Med. Assoc., 2003, 289, 1405.
• 40. Oksman M., Iivonen H., Hogyes E., et al.: Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol. Dis., 2006, 23, 563.
• 41. Owens J.: Milking nature for Alzheimer’s treatment. DDT 2001, 6, 17, 866.
• 42. Pickering G.: Frail elderly, nutritional status and drugs. Arch. Gerontol. Geriatr., 2004, 38,174.
• 43. Pirlich M., Lochs H.: Nutrition in the elderly. Best Pract. Res. Clin. Gastroenterol., 2001, 15,6,869.
• 44. Pitchumoni S.S., Doraiswamy P.M.: Current status of antioxidant therapy for Alzheimer’s Disease. J. Am. Geriatr. Soc., 1998, 46, 1566.
• 45. Planas M., Conde M., Audivert S.: Micronutrient supplementation in mild Alzheimer disease patients. Clin. Nutr., 2004, 23,265.
• 46. Rinaldi P., Polidori M.C., Metastasio A., et al.: Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol. Aging 2003,24, 915.
• 47. Salas-Salvado J., Torres M., Planas M., et al.: Effect of oral administration of a whole formula diet on nutritional and cognitive status in patients with Alzheimer’s disease. Clin. Nutr., 2005, 24, 390.
• 48. Scarmeas N., Luchsinger J.A., Mayeux R., et al.: Mediterranean diet and Alzheimer disease mortality. Neurology 2007, 69,1084.
• 49. Seshadri S., Beiser A., Selhub J., et al.: Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N. Engl. J. Med., 2002,346,476.
• 50. Seshadri S., Wolf P.A.: Homocysteine and the brain: vascular risk factor or neurotoxin? Lancet Neurol., 2003,2,11.
• 51. Solfrizzi V., Panza F., Capurso A.: The role of diet in cognitive decline. J. Neural. Transm., 2003,110, 95.
• 52. Staehelin H.B.: Micronutrients and Alzheimer’s disease. Proc. Nutr. Soc., 2005,64,565.
• 53. Stewart M.G., Banks D.: Enhancement of long-term memory retention by Colostrynin in one - day old chicks trained on a weak passive avoidance learning paradigm. Neurobiol. Learn Mem., 2006, 86, 66.
• 54. Truelsen T., Thudium D., Gronbaek M.: Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology 2002, 59,1313.
• 55. Vermeer S.E., Prins N.D., den Heijer T., et al.: Silent brain infarcts and the risk of dementia and cognitive decline. N. Eng. J. Med., 2003, 348, 1215.
• 56. Volkert D., Berner Y.N., Berry E., et al.: ESPEN Guidelines on Enteral Nutrition: Geriatrics. Clin. Nutr., 2006, 25, 330 - 360.
• 57. Wang H.X., Wahlin A., Basun H., et al.: Vitamin B12 and foliate in relation to development of Alzheimer’s disease. Neurology 2001, 56, 1188.
• 58. Zimecki M., Artym J.: Właściwości terapeutyczne białek i peptydów z siary i mleka. Post. Hig. Med. Dośw., 2005, 59,309.
• 59. Mazza M., Pomponi M., Janiri L., et al.: Omega 3- fatty AIDS and antioxidants in neurological and psychiatric diseases: An overview. Prog. Neuro-Psychop., 2007, 31,12.